Riggs Asset Managment Co. Inc. Recursion Pharmaceuticals, Inc. Transaction History
Riggs Asset Managment Co. Inc.
- $360 Million
- Q2 2025
A detailed history of Riggs Asset Managment Co. Inc. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Riggs Asset Managment Co. Inc. holds 59 shares of RXRX stock, worth $325. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59Holding current value
$325% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding RXRX
# of Institutions
367Shares Held
288MCall Options Held
7.76MPut Options Held
6.19M-
Vanguard Group Inc Valley Forge, PA36.1MShares$199 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$182 Million1.38% of portfolio
-
Baillie Gifford & CO24.2MShares$133 Million0.1% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$95.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$81 Million0.31% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $996M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...